Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy

Man‐Fung Yuen(University of Hong Kong - Shenzhen Hospital), Dickens Theodore, Jidong Jia(National Clinical Research Center for Digestive Diseases), Melanie Paff, Yasuhito Tanaka(Kumamoto University), Rajneesh Kumar(Singapore General Hospital), Michio Imamura(Hiroshima University), Madalinee Eternity Labio(Makati Medical Center), Kazuaki Chayama(RIKEN Center for Integrative Medical Sciences), Yoshiyasu Karino(Sapporo Kosei General Hospital), Hyung Joon Yim(Ansan University), Sharon Baptiste‐Brown, Jung‐Hwan Yoon(Seoul National University), Jeong Heo(National Cancer Center), Kelong Han(University of Pittsburgh), Wen Xie(Capital Medical University), Jinlin Hou(Southern Medical University), Matt Davies, Jennifer Cremer(Southern Medical University), Qing Xie(Ruijin Hospital), Judy Lao-Tan(Cebu Doctors' University), Fumitaka Suzuki(Toranomon Hospital), Masayuki Kurosaki(Musashino Red Cross Hospital), Yoshiyuki Suzuki(Nagoya City University), Tao Yu(Nanfang Hospital), Sung-Jae Park(Inje University Busan Paik Hospital), Fiona Campbell(University of Birmingham), Zhongping Duan(Capital Medical University), Seng Gee Lim(National University of Singapore), Hiromitsu Kumada(Toranomon Hospital), Robert C. Elston(University of North Carolina at Chapel Hill)
Journal of Hepatology
June 14, 2022
Cited by 55


Related Papers